One-Year Follow-Up of Feasibility and Safety of the First U.S., Randomized, Controlled Study Using 3-Dimensional Guided Catheter-Based Delivery of Autologous Skeletal Myoblasts for Ischemic Cardiomyopathy (CAuSMIC Study)

JACC: Cardiovascular Interventions

Volumn 2, Issue 1, 2009, Pages 9-16

  Dib, Nabil ^a   Dinsmore, Jonathan ^b   Lababidi, Zaki ^c   White, Bee ^c   Moravec, Susan ^c   Campbell, Ann ^c   Rosenbaum, Amy ^c   Seyedmadani, Katayoun ^c   Jaber, Wael A ^d   Rizenhour, Craig S ^c   Diethrich, Edward ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Mytogen Inc   (United States)

^c ARIZONA HEART INSTITUTE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

catheter; heart failure; muscle cell; myocardial infarction; transplant

Indexed keywords

ADULT; AGED; ARTICLE; AUTOLOGOUS SKELETAL MYOBLAST TRANSPLANTATION; CARDIOMYOPATHY; CELL TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART CATHETER; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RHYTHM; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; INTRACORONARY INFUSION; ISCHEMIC HEART DISEASE; MALE; MEDICAL INSTRUMENTATION; MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE; PATIENT SAFETY; PHASE 1 CLINICAL TRIAL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; UNITED STATES; AUTOTRANSPLANTATION; CARDIOMYOPATHY, DILATED; ECHOGRAPHY; HEART VENTRICLE; MIDDLE AGED; MYOBLAST; PATHOLOGY; THREE DIMENSIONAL IMAGING; TIME; TRANSPLANTATION;

AGED; CARDIOMYOPATHY, DILATED; FEASIBILITY STUDIES; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; MYOBLASTS, SKELETAL; QUALITY OF LIFE; QUESTIONNAIRES; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 58249112859     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2008.11.003     Document Type: Article

References (31)

1. Dib N., Michler R.E., Pagani F.D., et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 112 (2005) 1748-1755
2. Menasché P., Alfieri O., Janssens S., et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117 (2008) 1189-1200
3. Herreros J., Prosper F., Perez A., et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 24 (2003) 2012-2020
4. Menasche P. Skeletal muscle satellite cell transplantation. Cardiovasc Res 58 (2003) 351-357
5. Menasche P., Hagege A.A., Scorsin M., et al. Myoblast transplantation for heart failure. Lancet 357 (2001) 279-280
6. Menasche P., Hagege A.A., Vilquin J.T., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41 (2003) 1078-1083
7. Pagani F.D., DerSimonian H., Zawadzka A., et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 41 (2003) 879-888
8. Smits P.C., van Geuns R.J., Poldermans D., et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 42 (2003) 2063-2069
9. Siminiak T., Fiszer D., Jerzykowska O., et al. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. Eur Heart J 26 (2005) 1188-1195
10. Siminiak T., Kalawski R., Fiszer D., et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J 148 (2004) 531-537
11. Ghostine S., Carrion C., Souza L.C., et al. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 106 (2002) I131-I136
12. Jain M., DerSimonian H., Brenner D.A., et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 103 (2001) 1920-1927
13. McConnell P.I., del Rio C.L., Jacoby D.B., et al. Correlation of autologous skeletal myoblast survival with changes in left ventricular remodeling in dilated ischemic heart failure. J Thorac Cardiovasc Surg 130 (2005) 1001
14. Pouzet B., Vilquin J.T., Hagege A.A., et al. Intramyocardial transplantation of autologous myoblasts: can tissue processing be optimized?. Circulation 102 (2000) III210-III215
15. Pouzet B., Vilquin J.T., Hagege A.A., et al. Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann Thorac Surg 71 (2001) 844-850 discussion 850-1
16. Rajnoch C., Chachques J.C., Berrebi A., Bruneval P., Benoit M.O., and Carpentier A. Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg 121 (2001) 871-878
17. Scorsin M., Hagege A.A., Marotte F., et al. Does transplantation of cardiomyocytes improve function of infarcted myocardium?. Circulation 96 (1997) II188-II193
18. Taylor D.A., Atkins B.Z., Hungspreugs P., et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4 (1998) 929-933
19. Hagege A.A., Carrion C., Menasche P., et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 361 (2003) 491-492
20. Taylor D.A., Silvestry S.C., Bishop S.P., et al. Delivery of primary autologous skeletal myoblasts into rabbit heart by coronary infusion: a potential approach to myocardial repair. Proc Assoc Am Physicians 109 (1997) 245-253
21. Kornowski R., Hong M.K., Gepstein L., et al. Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium. Circulation 98 (1998) 1116-1124
22. Kornowski R., Leon M.B., Fuchs S., et al. Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models. J Am Coll Cardiol 35 (2000) 1031-1039
23. Kornowski R., Fuchs S., Tio F.O., Pierre A., Epstein S.E., and Leon M.B. Evaluation of the acute and chronic safety of the biosense injection catheter system in porcine hearts. Catheter Cardiovasc Interv 48 (1999) 447-453
24. Dib N., Campbell A., Jacoby D.B., et al. Safety and feasibility of percutaneous autologous skeletal myoblast transplantation in the coil-infarcted swine myocardium. J Pharmacol Toxicol Methods 53 (2006) 256-263
25. Ben-Dor I., Fuchs S., and Kornowski R. Potential hazards and technical considerations associated with myocardial cell transplantation protocols for ischemic myocardial syndrome. J Am Coll Cardiol 48 (2006) 1519-1526
26. Dib N., McCarthy P., Campbell A., et al. Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy. Cell Transplant 14 (2005) 11-19
27. Chazaud B., Hittinger L., Sonnet C., et al. Endoventricular porcine autologous myoblast transplantation can be successfully achieved with minor mechanical cell damage. Cardiovasc Res 58 (2003) 444-450
28. Dib N., Diethrich E.B., Campbell A., et al. Endoventricular transplantation of allogenic skeletal myoblasts in a porcine model of myocardial infarction. J Endovasc Ther 9 (2002) 313-319
29. Dinsmore J.H., and Dib N. An overview of myoblast transplantation for myocardial regeneration. Am Heart Hosp J 3 (2005) 146-152
30. Memon I.A., Sawa Y., Miyagawa S., Taketani S., and Matsuda H. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy. J Thorac Cardiovasc Surg 130 (2005) 646-653
31. Zheng B., Cao B., Crisan M., et al. Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol 25 (2007) 1025-1034